Our Pipeline Cytodigm’s Nanoparticle (NP) Technology:
Platform Pipeline
Learn More
PlatformsClassTargetPreclinicalPhase 1Phase 2Phase 3
ZETAFINITY®PNP
PNP		Antigen-Presenting Cells
Antigen-Presenting Cells
Cytofinity™LNP
LNP
LNP
Liver
Lung
Bone Marrow
Sigfinity™LPP
LPP		Lung
Eye
Cour Pharmaceuticals
Cour/Takeda
The Cytodigm IP portfolio focuses on the compositions, methods of use, & manufacturing of DDS technologies. This includes 13 PCTs & 7 granted US patents.

Zetafinity® has already been out-licensed for therapeutic indications outside oncology and is currently used in late-stage clinical trials.

content-image
Get more information about our technology